Sotatercept for Pulmonary Arterial Hypertension...

By Staff Writer

January 25, 2024

A New Ray of Hope Pulmonary arterial hypertension (PAH) is a rare, progressive disease characterised by the thickening of pulmonary artery walls, causing increased resistance and pressure that makes it dif...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.